Senior Software Engineer

ValGenesis welcomes David Horn as president. * October 6, 2026 ValGenesis announced the strategic appointment of David Horn as corporate president today. His official leadership appointment takes effect on October 5, 2026. Furthermore, Horn joins ValGenesis during an aggressive global expansion of its Smart GxP platform. He will focus on strengthening financial foundations and expanding international customer relationships. Additionally, he will collaborate directly with chief executive officer Siva Samy on long-term initiatives. Specifically, Horn brings over two decades of financial and operational experience to ValGenesis. Most recently, he served as president and chief financial officer at Seer, Inc. In that executive role, he directed core finance operations and key commercial functions. Previously, Horn spent over 20 years at Morgan Stanley as managing director. He led the global Life Science Tools practice and advised public life sciences companies. Earlier in his career, he directed business development across medical device sectors. "ValGenesis has significant opportunities ahead as we continue to grow and expand how we serve life sciences organizations," Samy said. "David brings a rare combination of operating leadership, financial expertise, and industry knowledge. His experience helping companies navigate growth and strategic change will strengthen our leadership team as we enter this next stage." "ValGenesis has built a strong position in life sciences, with deep customer relationships and significant innovation underway across its Smart GxP and VAL platforms," Horn said. "I'm excited to work with Siva and the broader ValGenesis team at this important stage in the company's growth and help realize the exciting opportunities ahead." Expanding leadership capabilities and modernizing GxP operations. Academic accomplishments further solidify his strategic business expertise across global markets. Horn holds a Bachelor of Arts degree from Princeton University. In addition, he earned an MBA from the Stanford Graduate School of Business. Consequently, this executive appointment accelerates the software innovation strategy at ValGenesis. The organization continues investing heavily in digital validation solutions for global life sciences leaders. Ultimately, his arrival positions ValGenesis to scale operations and modernize global GxP compliance workflows. For more stories on technology leaders shaping the future of enterprise solutions, visit its CXO Insiders.

ValGenesis to bring real-world AI-Assisted Validation insights to KENX Europe 2026. * 1 hr ago ValGenesis Inc., the leader in enterprise digital validation, will explore real-world insights into the practical application of AI-assisted validation at KENX Europe 2026: Harnessing the Power of AI in GxP, taking place Oct. 14-15, 2026, at the Four Elements Hotel Amsterdam in Amsterdam, the Netherlands. As life sciences organizations move from exploring AI's potential to applying it in regulated environments, questions around performance, governance, and human oversight are becoming increasingly important. ValGenesis is addressing these challenges through AI-native digital validation and VAL(TM)(ValGenesis AI), the governed AI natively built into the ValGenesis Smart GxP(TM) platform. VAL applies AI throughout the validation lifecycle while keeping humans in control of oversight, approval, and critical decisions. Its capabilities include generating validation documents, identifying potential compliance and test-coverage gaps, interpreting execution evidence, detecting anomalies, and analyzing document changes. "AI is moving beyond theory and into practical use in GxP environments," said David Medina, chief marketing officer at ValGenesis. "The challenge now is understanding where it adds meaningful value, how to evaluate the results, and how to maintain appropriate control. At KENX Europe, we'll share what we're learning from practical applications of AI in validation and the considerations organizations should address as they expand its use." Kenneth Pierce, Ph.D., director of product growth at ValGenesis, will lead two sessions focused on evaluating AI performance and building trust in its use in GxP environments. "How Would You Know It Worked? Measuring AI-Assisted Validation in Practice" will draw on customer pilot studies, implementation lessons, and measurable performance outcomes to examine how organizations can evaluate AI-assisted validation. "Pacing the Frontier: AI in GxP Life Sciences Operations" will introduce an AI maturity model for building trust in AI-supported processes and expanding adoption through clearly defined intended-use frameworks. ValGenesis is a Platinum Sponsor of KENX Europe 2026 and will host an exhibit booth and sponsor the event's cocktail reception. About ValGenesis, Inc. ValGenesis, Inc. is the global leader in enterprise digital validation. Serving the life sciences industry for nearly two decades, ValGenesis enables companies to digitize their commissioning, qualification, and validation processes through its AI-enabled ValGenesis Smart GxP(TM) platform, which includes solutions for risk management, cleaning validation, continued process verification, and CMC development. ValGenesis helps customers worldwide reduce costs, improve compliance, and accelerate innovation. For more information, visit valgenesis.com. Media gallery